2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide

C19H19N5O2 — CID 138586345

IUPAC2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide
SMILESO=C(CN1CCOCC1)Nc1cc2cc(-c3cccnn3)ccc2cn1
InChIInChI=1S/C19H19N5O2/c25-19(13-24-6-8-26-9-7-24)22-18-11-16-10-14(3-4-15(16)12-20-18)17-2-1-5-21-23-17/h1-5,10-12H,6-9,13H2,(H,20,22,25)
InChIKeyDWYFJIAVIZWOMN-UHFFFAOYSA-N
MW349.39 g/mol
LogP1.96
Rot. Bonds4

About 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide

2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide (PubChem CID 138586345) has the molecular formula C19H19N5O2 and a molecular weight of 349.39 g/mol. Its IUPAC name is 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide.

Molecular Properties

Compound Name2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide
PubChem CID138586345
Molecular FormulaC19H19N5O2
Molecular Weight349.39 g/mol
Exact Mass349.15
IUPAC Name2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide
SMILESO=C(CN1CCOCC1)Nc1cc2cc(-c3cccnn3)ccc2cn1
InChIInChI=1S/C19H19N5O2/c25-19(13-24-6-8-26-9-7-24)22-18-11-16-10-14(3-4-15(16)12-20-18)17-2-1-5-21-23-17/h1-5,10-12H,6-9,13H2,(H,20,22,25)
InChIKeyDWYFJIAVIZWOMN-UHFFFAOYSA-N
XLogP1.96
TPSA80.24 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500349.39
LogP ≤ 51.96
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-morpholin-4-yl-N-(3-pyridazin-3-yl-1,7-naphthyridin-6-yl)acetamide
CID 138588047
4-(morpholin-4-ylmethyl)-N-(6-pyridazin-3-ylisoquinolin-3-yl)cyclohexane-1-carboxamide
CID 138606041
2-morpholin-4-yl-N-(6-pyridazin-4-ylisoquinolin-3-yl)acetamide
CID 138586327
1-[4-(morpholin-4-ylmethyl)cyclohexyl]-2-(6-pyridazin-3-ylisoquinolin-3-yl)ethanone
CID 147432485
N-[6-[(Z)-1-amino-2-[amino(methyl)amino]ethenyl]isoquinolin-3-yl]-2-morpholin-4-ylacetamide
CID 166702399
4-(4-methylpiperazin-1-yl)-N-(6-pyridazin-3-ylisoquinolin-3-yl)piperidine-1-carboxamide
CID 138606080
3-(2,2-difluoroethylamino)-N-(6-pyridazin-3-ylisoquinolin-3-yl)cyclobutane-1-carboxamide
CID 138606088
N-[2-(5-methyl-3-pyridinyl)-1,6-naphthyridin-7-yl]-2-morpholin-4-ylacetamide
CID 138588302
N-[6-(1-methyltriazol-4-yl)isoquinolin-3-yl]morpholine-4-carboxamide
CID 138559189
N-[[4-[(4-methylpiperazin-1-yl)methyl]cyclohexyl]methyl]-6-pyridazin-3-ylisoquinolin-3-amine
CID 142575426
2-morpholin-4-yl-N-pyridin-3-ylacetamide
CID 124786353
N-[6-(2-methyl-1,3-thiazol-5-yl)isoquinolin-3-yl]-2-piperidin-1-ylacetamide
CID 166955080

Frequently Asked Questions

What is the IUPAC name of 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide?
The IUPAC name of 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide (CID 138586345) is 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide.
What is the SMILES notation for 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide?
The canonical SMILES for 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide is O=C(CN1CCOCC1)Nc1cc2cc(-c3cccnn3)ccc2cn1.
What is the InChIKey of 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide?
The InChIKey is DWYFJIAVIZWOMN-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H19N5O2/c25-19(13-24-6-8-26-9-7-24)22-18-11-16-10-14(3-4-15(16)12-20-18)17-2-1-5-21-23-17/h1-5,10-12H,6-9,13H2,(H,20,22,25).
What are the key properties of 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide?
2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide has a molecular weight of 349.39 g/mol, XLogP of 1.96, 4 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-morpholin-4-yl-N-(6-pyridazin-3-ylisoquinolin-3-yl)acetamide is sourced from PubChem (CID 138586345), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).